Molecule from worm could lead to new rheumatoid arthritis drugs

09/16/2008 | BBC

Parasitic nematode worms release a molecule called ES-62 that can inhibit inflammatory reactions responsible for certain diseases, Scottish researchers reported. They hope to create a synthetic version of the molecule to develop treatments for rheumatoid arthritis and other auto-immune disorders.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Associate Manager, Regulatory Affairs
Mahwah, NJ
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC